Request Fact Sheet
Thank you!
Your submission has been received!
Something went wrong while submitting the form.
Please try again

Biosplice Therapeutics

Restore health by delivering first-in-class therapies that harness alternative splicing

Status:
Exited
In Portfolio

Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing. Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative splicing. Alternative splicing is an essential biological mechanism that regulates the diversification of proteins in a cell, which, in turn, determines cell type and function. Biosplice’s target class governs the selection of tissue-specific mRNA splice sites, making them attractive, druggable targets within the cellular “command and control” center.

Prev
Next
No items found.